Literature DB >> 8616357

Adjuvant treatment with tamoxifen. Side effects may have been overstated.

M Baum, J Cuzick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8616357      PMCID： PMC2350845          DOI： 10.1136/bmj.312.7037.1036

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent.

Authors:  B Fisher; C Redmond
Journal:  J Natl Cancer Inst       Date:  1991-09-18       Impact factor: 13.506

2.  Long term adjuvant therapy for primary breast cancer.

Authors:  R D Bulbrook
Journal:  BMJ       Date:  1996-02-17

3.  Detection of endometrial carcinoma and hyperplasia in asymptomatic women.

Authors:  L G Koss; K Schreiber; S G Oberlander; H F Moussouris; M Lesser
Journal:  Obstet Gynecol       Date:  1984-07       Impact factor: 7.661

4.  The Royal Marsden Hospital pilot tamoxifen chemoprevention trial.

Authors:  T J Powles; A L Jones; S E Ashley; M E O'Brien; V A Tidy; J Treleavan; D Cosgrove; A G Nash; N Sacks; M Baum
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872
  4 in total
  1 in total

1.  Side effects of tamoxifen are distressing and common.

Authors:  A Ray; R C Leonard
Journal:  BMJ       Date:  1996-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.